Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Urinary Bladder Neoplasms 5Colorectal Neoplasms 2Appendiceal Neoplasms 2Anus Neoplasms 2Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pleural Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mediastinal Neoplasms 1HIV Infections 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anal Canal Carcinoma 1

Interventions

pembrolizumab 7Nivolumab 7Specimen Handling 6Mitomycin 6Magnetic Resonance Spectroscopy 6Capecitabine 6Radiotherapy 5Fluorouracil 4Drug Therapy 4Biopsy 4Radiation 3Paclitaxel 3Ipilimumab 3Fluorodeoxyglucose F18 3Carboplatin 3dehydroftorafur 2atezolizumab 2aldesleukin 2Tomography, X-Ray Computed 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Proctoscopy 2Mitozytrex 2Colonoscopy 2CTLA-4 Antigen 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1enzalutamide 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anus Neoplasms × Mitozytrex × 1 year × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡